RxDoctor Payments Data

Jennifer Bradley, PA

Surgical · Carmel, INNPI 1427145317

Payments from drug & device makers

What this record shows

Medtronic accounts for 74.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $3,218 and has fallen 76.0% since, to $771 in 2025. Among surgical clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,784in general payments, 2019–2025

Across 69 payments — averaging $69.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Novo Nordisk$254
  • Regeneron Healthcare Solutions, Inc.$225
  • AbbVie$182
  • Inari Medical, Inc.$152
  • Pfizer$124
  • plus $309 from 7 others

What the payments were for

  • Speaking & faculty fees$2,34049%
  • Food & beverage$2,44451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,784 in reported general payments places this provider in the 95th percentile of 130 surgical providers in Indiana.

See all surgical providers in Indiana

Medicare billing

Part B allowed, 2024
$6,919
Medicare patients
49
Services billed
60

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate43$647
Ondansetron OdtOndansetron78$486
Omeprazole55$474
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen78$340

Paid to pharmacies, not to this prescriber.

Other surgical in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →